Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Phillips

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the ratL M Burrell, R Chan, P A Phillips, et al.
Lancet (London, England)|June 10, 1995
The right not to know HIV-test resultsB L Nahlen, M M ter Kuile, J M Richters, et al.
Cancer Letters|June 17, 2011
Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathwayP A Phillips, V Sangwan, D Borja-Cacho, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1995
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonismL M Burrell, P A Phillips, J Risvanis, et al.
Gut|July 27, 2005
Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosisJ A McCarroll, P A Phillips, N Santucci, et al.
The American Journal of Physiology|August 5, 1998
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the ratL M Burrell, P A Phillips, J Risvanis, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the ratL M Burrell, P A Phillips, J M Stephenson, et al.
Biopharmaceutics & Drug Disposition|August 1, 1991
Pharmacokinetic comparison of a combination tablet of enalapril and hydrochlorothiazide with enalapril and hydrochlorothiazide tablets administered together and separatelyL G Howes, E L Conway, P A Phillips, et al.
Journal of Receptor Research|January 1, 1989
[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptorsJ M Kelly, J M Abrahams, P A Phillips, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 1994
Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertensionP A Phillips, K A Rolls, L M Burrell, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the ratL M Burrell, R Chan, P A Phillips, et al.
Lancet (London, England)|June 10, 1995
The right not to know HIV-test resultsB L Nahlen, M M ter Kuile, J M Richters, et al.
Cancer Letters|June 17, 2011
Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathwayP A Phillips, V Sangwan, D Borja-Cacho, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1995
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonismL M Burrell, P A Phillips, J Risvanis, et al.
Gut|July 27, 2005
Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosisJ A McCarroll, P A Phillips, N Santucci, et al.
The American Journal of Physiology|August 5, 1998
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the ratL M Burrell, P A Phillips, J Risvanis, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the ratL M Burrell, P A Phillips, J M Stephenson, et al.
Biopharmaceutics & Drug Disposition|August 1, 1991
Pharmacokinetic comparison of a combination tablet of enalapril and hydrochlorothiazide with enalapril and hydrochlorothiazide tablets administered together and separatelyL G Howes, E L Conway, P A Phillips, et al.
Journal of Receptor Research|January 1, 1989
[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptorsJ M Kelly, J M Abrahams, P A Phillips, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 1994
Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertensionP A Phillips, K A Rolls, L M Burrell, et al.
Pageof 17